Authors


Jori E. Fleisher, MD, MSCE

Latest:

Benefits of Martial Arts on Movement Disorders

This podcast discusses preliminary evidence about the effects of karate on quality of life and several measures of gait, balance, and mobility in patients with PD.


Joseph Kaizer

Latest:

Music Therapy Unites the Arts and Medicine to Help Patients

Two medical students who are conservatory-trained musicians describe a memorable performance at a center for older adults with dementia.


Esther Kim

Latest:

Music Therapy Unites the Arts and Medicine to Help Patients

Two medical students who are conservatory-trained musicians describe a memorable performance at a center for older adults with dementia.


Cesar Ochoa-Lubinoff, MD, MPH, FAAP

Latest:

Phase 2 Trial for Angelman Syndrome Underway

In this podcast, Heidi Moawad, MD interviews Cesar Ochoa-Lubinoff, MD, MPH, FAAP, about recent encouraging clinical trial results in patients with Angelman syndrome.


Amir Bishay, MD

Latest:

Genetic Testing for Huntington Disease

The profound consequences of the results guide decisions about testing. Who should be tested? And, just as important, who should not?


William S. Baek, MD, FAAN

Latest:

Connecting With Neurology Patients Through Music

An interview with a neurologist who found that merely writing medical articles cannot express the impact an illness can have on patients, both literally and emotionally.


Alex Kolevzon, MD

Latest:

Developing Targeted Therapeutics in Angelman Syndrome

The genomic revolution has led to increasing opportunities to address complex neurodevelopmental conditions, taking a genetics-first approach.


Deepa Burman, MD

Latest:

New Treatment for Rare Autoimmune Disease

A new treatment for NMOSD has been found to reduce relapse, decrease re-hospitalizations, and hinder the need to treat acute attacks with corticosteroids and plasma exchange.


Lary C. Walker, PhD

Latest:

Prion-like Molecular Mechanisms in Alzheimer Disease

Although Alzheimer disease is not infectious by any common definition of the term, research over the past 20 years has confirmed long-standing speculation that the molecular mechanism driving neurodegeneration is fundamentally the same in Alzheimer disease and the prototypical infectious proteopathy-prion disease.


Jessica Ailani, MD

Latest:

A Time to Recognize and Enhance Understanding of Migraine Disorders: Jessica Ailani, MD

The director of the MedStar Georgetown Headache Center talked about recognizing the struggles of patients with migraine disorders and the importance of bringing awareness of available treatments to this patient population. [WATCH TIME: 5 minutes]


Alicia Bigica

Latest:

FibroGen's Duchenne Muscular Dystrophy Antibody Pamrevlumab Falls Short in Phase 3

The study did not meet its primary end point of change from baseline in Performance of the Upper Limb 2.0 score at 1 year.


Jenna Payesko

Latest:

FDA Rejects Duchenne Muscular Dystrophy Drug Golodirsen, Citing Safety Concerns

The regulatory agency cited 2 concerns in the complete response letter: the risk of infections related to intravenous infusion ports and renal toxicity.


Uma Menon, MD, MBA

Latest:

Unusual New Onset Seizures in a Healthy, Young Adult Male

A 23-year-old male college student presents with first generalized tonic-clonic seizure followed by episodes of violent psychosis.


Matt Hoffman

Latest:

Advancing the Diagnostic Criteria for Multiple Sclerosis: A New Era of Early Detection and Precision

With new revisions of the MS diagnostic criteria being made, clinicians highlighted key updates and the broader implications it has for diagnosis, treatment, and healthcare practices worldwide.


Lauryn Currens, MD

Latest:

Using the Ketogenic Diet to Treat Intractable Epilepsy in Case of Glycine Encephalopathy

A boy diagnosed with glycine encephalopathy in the newborn period was initiated on the ketogenic diet at 11 years-old for the treatment of medication refractory epilepsy.


Mayte Sánchez van Kammen, MD

Latest:

Understanding Cerebral Venous Thrombosis: Rare But Sometimes Fatal

The prognosis of cerebral venous thrombosis (CVT) is favorable compared with other types of stroke: almost 80% of patients with CVT recover without functional disability. Nevertheless, 5% to 10% of patients die in the acute phase.


Susanna M. Zuurbier, MD, PhD

Latest:

Understanding Cerebral Venous Thrombosis: Rare But Sometimes Fatal

The prognosis of cerebral venous thrombosis (CVT) is favorable compared with other types of stroke: almost 80% of patients with CVT recover without functional disability. Nevertheless, 5% to 10% of patients die in the acute phase.


Jonathan M. Coutinho, MD, PhD

Latest:

Understanding Cerebral Venous Thrombosis: Rare But Sometimes Fatal

The prognosis of cerebral venous thrombosis (CVT) is favorable compared with other types of stroke: almost 80% of patients with CVT recover without functional disability. Nevertheless, 5% to 10% of patients die in the acute phase.


Laura C. Spetlz, MD

Latest:

Case Report: New Onset Paroxysmal Episodes in an Infant

A newborn presents with new onset episodes of lateral gaze deviation with extremity stiffening.


Tori Rodriguez, MA

Latest:

Closing the Treatment Gap in Progressive MS

New biomarkers of disease activity may help better vet investigational therapies aimed at slowing the insidious neurodegeneration seen in primary progressive multiple sclerosis.


Marco Meglio

Latest:

New Investigator-Initiated Study to Test CYR-064 for Hyposmia in Parkinson Disease

The 32-week study will enroll 15–20 adults aged 18–80 with Parkinson's-related hyposmia, featuring a 24-week treatment period of twice-daily CYR-064 nasal sprays.


Lauren Speltz, MD

Latest:

Cyclic Vomiting, Incontinence in a Young Boy

An 8 year old boy with genetically confirmed neurofibromatosis type 1 presents with first generalized seizure.

© 2025 MJH Life Sciences

All rights reserved.